Electronic Clinical Decision Support for Middle Eastern Hospitals

First DataBankHospitals in the Middle East are set to benefit from sophisticated electronic clinical decision support following the commercial agreement between First DataBank International (FDB International) and GE Healthcare (GE). This agreement builds on the relationship which First DataBank has with GE Healthcare's Information Technology business in the US.

GE's Centricity® Enterprise, will provide Middle Eastern customers with electronic dispensing and prescribing functionality, with clinical decision support enabled by the integration of FDB International's drug knowledge base. Healthcare providers can use Centricity® Enterprise to help verify the medication about to be prescribed or dispensed to a patient against the patient's profile. On-screen alerts help a provider to determine if there may be a potential drug interaction, duplicate therapy, sensitivity, contraindication or precaution.

Centricity® Enterprise is an integrated clinical, financial and administrative system that helps caregivers provide enhanced patient care through computerized physician order entry (CPOE), clinical decision support and expert rules, while documenting all aspects of patient care. The system integrates core clinical processes for orders, results, pharmacy and care documentation, in concert with administrative/financial processes for scheduling, registration/admitting, charging and billing.

"This agreement gives us access to invaluable information which will immediately benefit our product," said Juergen Reyinger, EMEA vice president and general manager of GE Healthcare IT. "We look forward to working with First DataBank International in growing our solution and benefiting from their strengths, just as they will surely benefit from ours."

David Flavell, President, FDB International adds: "The Middle East is a key region in our international expansion plans as its healthcare systems are developing so rapidly. Our agreement with GE is significant as it will bring more advanced clinical decision support to hospitals in the region, helping providers to enhance patient safety by helping them reduce the occurrence of medical errors."

First DataBank continues to expand its global presence with customers across the Middle East, Asia Pacific, Australasia, Africa and Europe as well as continuing to grow its long established North American and UK markets.

Related news articles:

About First DataBank
First DataBank (FDB) is the world's leading provider of drug knowledge bases and active clinical decision support. With over 30 years' experience of maintaining, developing and integrating drug knowledge bases across the entire healthcare spectrum, FDB has unrivalled expertise and knowledge in this specialist field. NHS Connecting for Health has chosen FDB to provide drug-related clinical decision support.

Patient safety is the driving force behind our business. Through the effective integration of our products into clinical systems, we enable safer prescribing, dispensing and administration.

For further information visit www.firstdatabank.co.uk.

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease. For further information visit www.gehealthcare.com.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...